WOK — Work Medical Technology Balance Sheet
0.000.00%
- $0.16m
- $13.82m
- $11.51m
Annual balance sheet for Work Medical Technology, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.2 | 0.509 | 0.731 | 1.6 | 6.56 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 25.7 | 11 | 10.8 | 14.5 | 9.22 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 40.4 | 18.1 | 16.6 | 22.2 | 20.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 14.8 | 11.5 | 7.98 | 6.74 | 11.4 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 56.2 | 30.7 | 25.5 | 30 | 36.3 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 49.6 | 18.9 | 14.3 | 18.9 | 20.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 51.3 | 20.6 | 15.5 | 20.1 | 23.1 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4.9 | 10 | 10 | 9.88 | 13.2 |
| Total Liabilities & Shareholders' Equity | 56.2 | 30.7 | 25.5 | 30 | 36.3 |
| Total Common Shares Outstanding |